Loading organizations...
§ Venture Capital
Micro-venture capital firm investing in early-stage tech startups, focusing on B2B sectors like SaaS, fintech, and edtech.
Bossa Invest operates as a venture capital firm dedicated to fostering the growth of the startup ecosystem through strategic investments and comprehensive support. The company provides capital, smart money, and mentorship, coupled with an extensive network, to accelerate the development of innovative businesses. They also create avenues for individual investors to participate in the startup market and facilitate Corporate Venture Capital (CVC) programs for larger enterprises seeking to integrate innovation.
Established in 2011, the firm began its journey as Bossanova before evolving into Bossa Invest. This transition underscored a deepened commitment to building a robust innovation ecosystem. The foundational insight driving the firm's inception was the recognition of startups' potential to drive new economies, necessitating a connected and strategic approach to investment and growth.
The firm serves a diverse clientele including startups seeking crucial investment and development resources, individual investors looking to strategically engage with the venture capital landscape, and corporations aiming to innovate through collaboration with nascent companies. Bossa Invest's overarching vision is to empower entrepreneurs, propel businesses forward, and strengthen communities by positively transforming the world through an active and supportive investment ecosystem.
Bossa Ventures has 2 tracked investments across 1 company. The latest tracked deal is $53.0M Other Equity in Rani Therapeutics in February 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 8, 2018 | Rani Therapeutics | $53.0M Other Equity | — | AstraZeneca, Cathay Venture, GeneScience Pharmaceuticals, GV, Novartis, Ping AN Ventures, Shire, Virtus Ventures |
| Feb 1, 2018 | Rani Therapeutics | $53.0M Series U | — | Byers Capital, Founders' Co OP, Seven Seven SIX, Susa Ventures, Y Combinator, Justin Mateen, AstraZeneca, Cathay Venture, GeneScience Pharmaceuticals, GV, Novartis, Ping AN Ventures, Shire, Virtus Ventures |